Predictive Value of a Profile of Routine Blood Measurements on Mortality in Older Persons in the General Population: the Leiden 85-plus Study
Overview
Authors
Affiliations
Background: Various questionnaires and performance tests predict mortality in older people. However, most are heterogeneous, laborious and a validated consensus index is not available yet. Since most older people are regularly monitored by laboratory tests, we compared the predictive value of a profile of seven routine laboratory measurements on mortality in older persons in the general population with other predictors of mortality; gait speed and disability in instrumental activities of daily living (IADL).
Methodology/principal Findings: Within the Leiden 85-plus Study, a prospective population-based study, we followed 562 participants aged 85 years for mortality over five years. At baseline (age 85 years) high-density lipoprotein cholesterol, albumin, alanine transaminase, hemoglobin, creatinin clearance, C-reactive protein and homocysteine were measured. Participants were stratified based on their number of laboratory abnormalities (0, 1, 2-4 and 5-7). The predictive capacity was compared with gait speed (6-meter walking test) and disability in IADL (Groningen Activity Restriction Scale) by C-statistics. At baseline, 418 (74%) 85-year old participants had at least one laboratory abnormality. All cause mortality risk increased with increasing number of laboratory abnormalities to a hazard ratio of 5.64 [95% CI 3.49-9.12] for those with 5-7 laboratory abnormalities (p<0.001) compared to those without abnormalities. The c-statistic was 0.66 [95% CI 0.59-0.69], similar to that of gait speed and disability in IADL.
Conclusions/significance: In the general population of oldest old, the number of abnormalities in seven routine laboratory measurements predicts five-year mortality as accurately as gait speed and IADL disability.
van der Ploeg M, Poortvliet R, Bogaerts J, van der Klei V, Kerse N, Rolleston A J Gerontol A Biol Sci Med Sci. 2023; 78(9):1708-1716.
PMID: 37314150 PMC: 10460558. DOI: 10.1093/gerona/glad148.
Wang P, Gussekloo J, Arai Y, Abe Y, Blom J, Duncan R BMC Geriatr. 2021; 21(1):457.
PMID: 34372781 PMC: 8351428. DOI: 10.1186/s12877-021-02389-2.
One-Carbon Metabolism Biomarkers and Cognitive Decline in the Very Old: The Newcastle 85+ Study.
Mendonca N, Granic A, Mathers J, Martin-Ruiz C, Wesnes K, Seal C J Am Med Dir Assoc. 2017; 18(9):806.e19-806.e27.
PMID: 28647580 PMC: 5576913. DOI: 10.1016/j.jamda.2017.05.008.
Hofman S, Lucke J, Heim N, de Gelder J, Fogteloo A, Heringhaus C BMC Emerg Med. 2016; 16(1):26.
PMID: 27412243 PMC: 4944462. DOI: 10.1186/s12873-016-0090-5.
Formiga F, Ferrer A, Padros G, Montero A, Gimenez-Argente C, Corbella X Clin Interv Aging. 2016; 11:437-44.
PMID: 27143867 PMC: 4841391. DOI: 10.2147/CIA.S101447.